Insider Trading March 27, 2026

AAR CORP Director Sells 1,562 Shares as Company Reports Strong Q3 Results

Billy Nolen disposes of stake on March 26, 2026; AAR posts EPS and revenue beats that draw analyst price-target increases

By Caleb Monroe AIR
AAR CORP Director Sells 1,562 Shares as Company Reports Strong Q3 Results
AIR

AAR CORP director Billy Nolen sold 1,562 shares on March 26, 2026, for $173,384 at a weighted average price between $111.0000 and $111.0100. The company recently reported third-quarter fiscal 2026 results that outperformed expectations, prompting multiple firms to raise price targets and maintain or reaffirm Buy ratings.

Key Points

  • Director Billy Nolen sold 1,562 AAR CORP shares on March 26, 2026, for $173,384 at a weighted average price between $111.0000 and $111.0100.
  • AAR reported Q3 FY2026 EPS of $1.25 (vs. $1.16 expected) and revenue of $845 million (vs. $812.2 million expected), prompting several analyst price-target increases.
  • Following the sale Nolen directly owns 0 shares; the transaction was signed by Katherine Kwiat under a power of attorney.

Director Billy Nolen executed a sale of 1,562 shares of AAR CORP (NYSE:AIR) common stock on March 26, 2026, bringing in proceeds of $173,384. The shares were sold at a weighted average price in the narrow band from $111.0000 to $111.0100.

After the transaction, Nolen no longer holds any direct shares of AAR CORP. The trade was completed on March 26, 2026, and the paperwork indicates the transaction was signed on his behalf by Katherine Kwiat under a power of attorney.

Market context for the sale: AAR stock has risen 62% over the prior 12 months. As of the latest reference point in the filing, shares were trading at $108.98.


Company performance and analyst response

AAR Corporation reported third-quarter results for fiscal year 2026 that exceeded consensus estimates on both the earnings and revenue lines. The company posted earnings per share of $1.25, topping the expected $1.16, and reported revenue of $845 million versus an anticipated $812.2 million.

Following those results, a number of analyst firms adjusted their outlooks:

  • Jefferies raised its price target to $150 and kept a Buy rating.
  • RBC Capital raised its price target to $125, citing the company’s strong performance.
  • Truist Securities reiterated a Buy rating and set a $128 price target, highlighting robust parts distribution growth.
  • KeyBanc increased its price target to $120, noting AAR’s execution in gaining market share and achieving operational efficiencies.

These analyst moves and the company’s reported results signal positive momentum and reflect the market’s response to AAR’s recent operational and financial performance.


Summary of the transaction and recent developments

  • Insider sale: 1,562 shares sold by director Billy Nolen on March 26, 2026, for $173,384.
  • Sale price range: weighted average between $111.0000 and $111.0100.
  • Post-sale ownership: Nolen holds 0 direct shares.
  • Execution: transaction signed by Katherine Kwiat under power of attorney.
  • Company performance: Q3 FY2026 EPS of $1.25 and revenue of $845 million, both above expectations.
  • Analyst actions: multiple firms raised price targets and/or reiterated Buy ratings following the results.

Risks

  • Insider disposition - The director’s sale reduces direct insider ownership which may be viewed as a negative signal by some investors; this impacts equity and corporate governance considerations.
  • Market sensitivity to results - Future market reaction may hinge on continued operational performance and parts distribution growth, which affects aerospace and aviation suppliers.
  • Analyst expectations - Price-target adjustments introduce variability in investor sentiment; if future quarters do not meet elevated expectations, stock volatility could increase, impacting equity markets tied to aerospace suppliers.

More from Insider Trading

Insider Sells $100,350 in First Interstate Bancsystem Shares; Reporting Owners Still Hold 933,024 Shares Mar 27, 2026 Kopin CEO Disposes of $77,234 in Shares as Company Wrestles with Revenue Shortfall Mar 27, 2026 RENN Fund President Purchases 1,134 RCG Shares in Late-March Trade Mar 27, 2026 Tecogen Director Lewis Earl Buys 5,000 Shares Worth $14,408 Amid Earnings Shortfall Mar 27, 2026 Insider Buy: Jorey Chernett Adds $157,500 in Oncology Institute Stock Mar 27, 2026